EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Primary Myelofibrosis vs. Multiple Myeloma-Associated Bone Marrow Fibrosis: When Treatment Response Clarifies the Diagnosis

Dolly Viviana Fiallo-Suárez, Ruth Stuckey, Angelina Lemes-Castellano, Alexia Suárez-Cabrera, Lidia González Hernández, Miguel Angel Limeres González, Yanira Florido, Cristina Bilbao-Sieyro, Miguel Perera-Álvarez, Leslie González Pinedo, Melania Moreno Vega, Melissa Torres Ochando und 5 weitere

Hemato · 30.05.2026 · 7 (2) · 19

DOI: 10.3390/hemato7020019 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hemato, online erschienen am 30.05.2026. Verfasst von Dolly Viviana Fiallo-Suárez und 16 weiteren Autor:innen. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The concomitant occurrence of myeloproliferative neoplasms (MPNs) and plasma cell dyscrasias is rare and presents significant diagnostic challenges. Accurate distinction between overlapping features is essential, particularly when bone marrow fibrosis (BMF) is present. Case Description: We report a 57-year-old female, with a 10-year history of thrombocytosis managed with antiplatelet therapy, who presented with anemia and severe lumbar pain. Bone marrow biopsy revealed marked fibrosis, and imaging revealed multiple vertebral lesions. Diagnostic workup identified features consistent with myelofibrosis (MF) and coexisting IgG-Kappa multiple myeloma (MM). Although the patient initially fulfilled WHO criteria for MF, the rapid resolution of fibrosis following first-line plasma-cell-directed therapy suggested a secondary, cytokine-mediated process rather than a true concomitant MPN.

Conclusions

This case highlights the importance of an integrated diagnostic approach in patients with overlapping features of hematologic malignancies. Differentiating between MM-associated fibrosis and true concurrent MPN and MM is critical, as misclassification may alter both prognosis and therapeutic strategy. In triple-negative cases, the histologic response to plasma-cell-directed therapy can serve as a key discriminating criterion. Awareness of the potential association between MM with fibrosis and extramedullary disease is also essential for clinical management. This case underscores the importance of an integrated diagnostic approach in patients with overlapping hematologic features.

Zitieren

APA

Fiallo-Suárez, D. V., Stuckey, R., Lemes-Castellano, A., Suárez-Cabrera, A., Hernández, L. G., González, M. A. L., Florido, Y., Bilbao-Sieyro, C., Perera-Álvarez, M., Pinedo, L. G., Vega, M. M., Ochando, M. T., Perera, M. D. M., Fleitas, C. A., Rodríguez, J. F. L., Sánchez, J. M. B., & Gómez-Casares, M. T. (2026). Primary Myelofibrosis vs. Multiple Myeloma-Associated Bone Marrow Fibrosis: When Treatment Response Clarifies the Diagnosis. Hemato, 7(2), 19. https://doi.org/10.3390/hemato7020019

Vancouver

Fiallo-Suárez DV, Stuckey R, Lemes-Castellano A, Suárez-Cabrera A, Hernández LG, González MAL, et al. Primary Myelofibrosis vs. Multiple Myeloma-Associated Bone Marrow Fibrosis: When Treatment Response Clarifies the Diagnosis. Hemato. 2026;7(2):19. doi:10.3390/hemato7020019

BibTeX
@article{FialloSurez2026,
  author = {Fiallo-Suárez, Dolly Viviana and Stuckey, Ruth and Lemes-Castellano, Angelina and Suárez-Cabrera, Alexia and Hernández, Lidia González and González, Miguel Angel Limeres and Florido, Yanira and Bilbao-Sieyro, Cristina and Perera-Álvarez, Miguel and Pinedo, Leslie González and Vega, Melania Moreno and Ochando, Melissa Torres and Perera, Maria del Mar and Fleitas, Cynthia Acosta and Rodríguez, Juan Francisco López and Sánchez, Juan Miguel Barbero and Gómez-Casares, María Teresa},
  title = {Primary Myelofibrosis vs. Multiple Myeloma-Associated Bone Marrow Fibrosis: When Treatment Response Clarifies the Diagnosis},
  journal = {Hemato},
  year = {2026},
  volume = {7},
  number = {2},
  pages = {19},
  doi = {10.3390/hemato7020019}
}
Kostenlos starten →